24.72
Spyglass Pharma Inc (SGP) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Operating Expenses |
42.56%
21.97
|
15.41 | - | - | - |
| Operating Income/Loss |
42.56%
-21.97
|
-15.41 | - | - | - |
| Nonoperating Income/Loss |
32.18%
2.103
|
1.591 | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
43.75%
-19.86
|
-13.82 | 13,889.30 | 4,499.00 | 4,647.00 |
| Income Tax Expense/Benefit |
-
|
- | 1,939.60 | 97.00 | 102.00 |
| Net Income/Loss |
43.75%
-19.86
|
-13.82 | 11,033.20 | 515.00 | 671.00 |
| Basic Average Shares |
67.80%
33.44
|
19.93 | - | - | - |
| Diluted Average Shares |
67.80%
33.44
|
19.93 | - | - | - |
| Basic Earnings Per Share |
14.49%
-0.59
|
-0.69 | 4.53 | 0.29 | 0.38 |
| Diluted Earnings Per Share |
14.49%
-0.59
|
-0.69 | 4.52 | 0.29 | 0.38 |
자본화:
|
볼륨(24시간):